SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway.
Kumarswamy R, Lyon AR, Volkmann I, Mills AM, Bretthauer J, Pahuja A, Geers-Knörr C, Kraft T, Hajjar RJ, Macleod KT, Harding SE, Thum T.
Kumarswamy R, et al. Among authors: thum t.
Eur Heart J. 2012 May;33(9):1067-75. doi: 10.1093/eurheartj/ehs043. Epub 2012 Feb 23.
Eur Heart J. 2012.
PMID: 22362515
Free PMC article.